Current Report Filing (8-k)
November 07 2017 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2017
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-14057
|
|
61-1323993
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
680 South Fourth Street
Louisville, Kentucky
(Address of principal executive offices)
40202
(Zip Code)
Registrants telephone number, including area code:
(502) 596-7300
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 2.02.
|
Results of Operations and Financial Condition.
|
On November 6, 2017, Kindred
Healthcare, Inc. (the Company) issued a press release announcing its financial results for the third quarter ended September 30, 2017. The press release, dated November 6, 2017, is attached as Exhibit 99.1 to this Form
8-K.
On November 6, 2017, the Company also made the press release available on its website at
www.kindredhealthcare.com
.
The information contained herein is being furnished pursuant to Item 2.02 of Form
8-K,
Results of Operations and Financial Condition. This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by
reference in any filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, nor shall this information be deemed incorporated by reference into any filing made by the Company under the Securities Act
or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 7.01.
|
Regulation FD Disclosure.
|
Incorporated by reference is Exhibit 99.1 attached hereto, a
press release issued by the Company on November 6, 2017 announcing its financial results for the third quarter ended September 30, 2017. This information is being furnished under Item 7.01 and shall not be deemed filed for
purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of such section nor shall this information be deemed incorporated by reference into any filing made by the Company under the Securities Act or the Exchange Act,
except as expressly set forth by specific reference in such a filing.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
KINDRED HEALTHCARE, INC.
|
|
|
|
|
Date: November 7, 2017
|
|
|
|
By:
|
|
/s/ Joseph L. Landenwich
|
|
|
|
|
|
|
Joseph L. Landenwich
|
|
|
|
|
|
|
General Counsel and Corporate Secretary
|
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Apr 2023 to Apr 2024